Elanco CEO buys 4,971 shares in open market

Elanco Animal Health President and CEO Jeffrey N. Simmons reported an open-market purchase and a compensation-related award.

Rhea-AI Filing Summary

Elanco Animal Health President and CEO Jeffrey N. Simmons reported an open-market purchase and a compensation-related award. A revocable trust associated with him bought 4,971 shares of common stock at $20.085 per share, bringing its indirect holdings to 171,971 shares. Separately, he received 142.3429 deferred stock units, each representing the right to one share of common stock or the cash equivalent, to be settled after employment ends or in a specified future year under the company’s Executive Deferral and Stock Match Plan. Following these updates, he directly holds 2,051,898 common shares and 24,306.4587 deferred stock units.

Insider Trade Summary

Net Buyer: 4,971 shares

Net Buy 3 txns

Insider Simmons Jeffrey N

Role PRESIDENT, CEO AND DIRECTOR

Bought 4,971 shs ($100K)

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Units	142.3429	$19.86	$3K
Purchase	Common Stock	4,971	$20.085	$100K
holding	Common Stock	--	--	--

Holdings After Transaction: Deferred Stock Units — 24,306.4587 contracts (Direct); Common Stock — 171,971 shares (Indirect, By Revocable Trust); Common Stock — 2,051,898 shares (Direct)

Footnotes (2)

1. F1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
2. F2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

Key Figures

Open-market purchase: 4,971 shares Purchase price: $20.085 per share Direct common shares: 2,051,898 shares +3 more

6 metrics

Open-market purchase 4,971 shares Common Stock bought by revocable trust

Purchase price $20.085 per share Price for 4,971 common shares

Direct common shares 2,051,898 shares Direct holdings after transactions

Indirect common shares 171,971 shares Held by revocable trust after purchase

Deferred stock units granted 142.3429 units New DSU award on report date

Total deferred stock units 24,306.4587 units DSU holdings after award

Key Terms

Deferred Stock Units, Revocable Trust, Executive Deferral and Stock Match Plan

3 terms

Deferred Stock Units financial

"Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent."

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

Revocable Trust financial

"Indirect ownership is listed as "By Revocable Trust" for the purchased shares."

A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.

Executive Deferral and Stock Match Plan financial

"Deferred stock units settle in cash or shares ... in accordance with Executive Deferral and Stock Match Plan."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Elanco (ELAN) CEO Jeffrey N. Simmons report in this Form 4?

Jeffrey N. Simmons reported an open-market purchase and a deferred stock unit award. A revocable trust bought 4,971 Elanco common shares, and he received 142.3429 deferred stock units tied to future settlement in cash or stock.

How many Elanco (ELAN) shares did the CEO’s revocable trust buy and at what price?

The revocable trust associated with the CEO bought 4,971 Elanco common shares at $20.085 per share. This transaction increased the trust’s indirect holdings to 171,971 shares of Elanco common stock as of the reported date.

What are the deferred stock units reported by Elanco (ELAN) CEO Simmons?

The CEO received 142.3429 deferred stock units, each equal to one Elanco common share or its cash equivalent. These units settle after employment ends or in a specified future year under the Executive Deferral and Stock Match Plan.

When will Elanco (ELAN) deferred stock units granted to the CEO be settled?

The deferred stock units will settle in cash or Elanco common shares following termination of employment or during a specified future year, in accordance with the company’s Executive Deferral and Stock Match Plan described in the filing footnotes.

What are Jeffrey N. Simmons’ total Elanco (ELAN) share holdings after these transactions?

After the reported transactions, Jeffrey N. Simmons directly holds 2,051,898 Elanco common shares. Indirectly, a revocable trust holds 171,971 shares, and he has 24,306.4587 deferred stock units linked to Elanco common stock value.

Is the Elanco (ELAN) CEO’s stock purchase an open-market transaction?

Yes. The Form 4 labels the 4,971-share transaction with code P, indicating an open-market or privately negotiated purchase. The shares were acquired at $20.085 each and are held indirectly through a revocable trust associated with the CEO.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/19/2026 - 04:38 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Simmons Jeffrey N

(Last) (First) (Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS INDIANA 46221

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	PRESIDENT, CEO AND DIRECTOR

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/15/2026		P		4,971	A	$20.085	171,971	I	By Revocable Trust
Common Stock								2,051,898	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	05/15/2026		A		142.3429		(2)	(2)	Common Stock	142.3429	$19.86	24,306.4587	D

Explanation of Responses:

1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.

2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

	/s/ Amy C. Seidel, as Attorney-in-Fact for Jeffrey N. Simmons	05/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)